Related references
Note: Only part of the references are listed.Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation
Stephen J. Ralph et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
G-Quadruplex Structure Improves the Immunostimulatory Effects of CpG Oligonucleotides
Kazuaki Hoshi et al.
NUCLEIC ACID THERAPEUTICS (2019)
DNA Nanotechnology Enters Cell Membranes
Shuaidong Huo et al.
ADVANCED SCIENCE (2019)
DNA nanostructures in vitro, in vivo and on membranes
Wooli Bae et al.
NANO TODAY (2019)
Fast, Efficient, and Targeted Liposome Delivery Mediated by DNA Hybridization
Hongyan Li et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Soft matter DNA nanoparticles hybridized with CpG motifs and peptide nucleic acids enable immunological treatment of cancer
Jun-O Jin et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Hyperconjugation-induced chromism in linear responsive polymers
Yeol Kyo Choi et al.
JOURNAL OF MATERIALS CHEMISTRY C (2019)
DNA nanotechnology
Nadrian C. Seeman et al.
NATURE REVIEWS MATERIALS (2018)
Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction
Zongmin Zhao et al.
BIOMATERIALS (2018)
Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues
Lingwei Wang et al.
NANOMEDICINE (2018)
Improving Vaccine and Immunotherapy Design Using Biomaterials
Michelle L. Bookstaver et al.
TRENDS IN IMMUNOLOGY (2018)
Performing DNA nanotechnology operations on a zebrafish
Jian Yang et al.
CHEMICAL SCIENCE (2018)
Administration of Soft Matter Lipid-DNA Nanoparticle As the Immunostimulant via Multiple Routes of Injection in Vivo
Jun-O Jin et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Administration of Soft Matter Lipid-DNA Nanoparticle As the Immunostimulant via Multiple Routes of Injection in Vivo
Jun-O Jin et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Modular delivery of CpG-incorporated lipid-DNA nanoparticles for spleen DC activation
Jun-O Jin et al.
BIOMATERIALS (2017)
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells
Rasmus Offersen et al.
JOURNAL OF VIROLOGY (2016)
Martini Coarse-Grained Force Field: Extension to DNA
Jaakko J. Uusitalo et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Immunomodulatory spherical nucleic acids
Aleksandar F. Radovic-Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD
Bo Zhou et al.
SCIENTIFIC REPORTS (2015)
Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy
Steven E. Bosinger et al.
CURRENT HIV/AIDS REPORTS (2015)
Designer three-dimensional DNA architectures
Yonggang Ke
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
CHARMM-GUI Membrane Builder Toward Realistic Biological Membrane Simulations
Emilia L. Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2014)
Nuclease-Resistant DNA via High-Density Packing in Polymeric Micellar Nanoparticle Coronas
Anthony M. Rush et al.
ACS NANO (2013)
Methamphetamine Inhibits Toll-Like Receptor 9-Mediated Anti-HIV Activity in Macrophages
Ping Cen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Optimization of the CHARMM Additive Force Field for DNA: Improved Treatment of the BI/BII Conformational Equilibrium
Katarina Hart et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination
Eileah Loda et al.
REVIEWS IN THE NEUROSCIENCES (2012)
Cellular Immunostimulation by CpG-Sequence-Coated DNA Origami Structures
Verena J. Schueller et al.
ACS NANO (2011)
Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulatory CpG Oligonucleotides
Jiang Li et al.
ACS NANO (2011)
DNA in a modern world
Eugen Stulz et al.
CHEMICAL SOCIETY REVIEWS (2011)
DNA origami: a quantum leap for self-assembly of complex structures
Thomas Torring et al.
CHEMICAL SOCIETY REVIEWS (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
Natural Killer Cell Responses to Viral Infection
Joshua D. Brandstadter et al.
JOURNAL OF INNATE IMMUNITY (2011)
Challenges and opportunities for structural DNA nanotechnology
Andre V. Pinheiro et al.
NATURE NANOTECHNOLOGY (2011)
Pattern Recognition Receptors and the Innate Immune Response to Viral Infection
Mikayla R. Thompson et al.
VIRUSES-BASEL (2011)
Type I interferons: diversity of sources, production pathways and effects on immune responses
Melissa Swiecki et al.
CURRENT OPINION IN VIROLOGY (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
DCs and NK cells: critical effectors in the immune response to HIV-1
Marcus Altfeld et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Tunable Hydrophobicity in DNA Micelles: Design, Synthesis, and Characterization of a New Family of DNA Amphiphiles
Milena Anaya et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Innate Immune Activation in Primary HIV-1 Infection
J. Judy Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types
Jeffery B. Klauda et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Virus-like Particles Templated by DNA Micelles: A General Method for Loading Virus Nanocarriers
Minseok Kwak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
Dennis M. Klinman et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Interferons and viral infections
Volker Fensterl et al.
BIOFACTORS (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA
Christoph Coch et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Impaired Plasmacytoid Dendritic Cell (PDC)-NK Cell Activity in Viremic Human Immunodeficiency Virus Infection Attributable to Impairments in both PDC and NK Cell Function
Sara J. Conry et al.
JOURNAL OF VIROLOGY (2009)
DNA block copolymer micelles - A combinatorial tool for cancer Nanotechnology
Fikri E. Alemdaroglu et al.
ADVANCED MATERIALS (2008)
Innate immune response to viral infection
Shohei Koyama et al.
CYTOKINE (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases
Kaveri Gupta et al.
DRUGS IN R&D (2008)
NK cell lysis of HIV-1-infected autologous CD4 primary T cells: Requirement for IFN-mediated NK activation by plasmacytoid dendritic cells
Costin Tomescu et al.
JOURNAL OF IMMUNOLOGY (2007)
Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing Antiretroviral treatment
Jihed Chehimi et al.
JOURNAL OF IMMUNOLOGY (2007)
Type I interferon production in HIV-infected patients
Anne Hosmalin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
RD Weeratna et al.
VACCINE (2005)
Production of type I interferons: plasmacytoid dendritic cells and beyond
C Asselin-Paturel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection
I Kamga et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection
M Ayash-Rashkovsky et al.
FASEB JOURNAL (2005)
NK cells in innate immunity
JA Hamerman et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Endogenous IFN-α production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection
KB Gurney et al.
JOURNAL OF IMMUNOLOGY (2004)
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells
S Sivori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo
E Schlaepfer et al.
JOURNAL OF VIROLOGY (2004)
Use of CpG oligodeoxynucleotides as immune adjuvants
DM Klinman et al.
IMMUNOLOGICAL REVIEWS (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type IIFN synthesis in human plasmacytoid dendritic cells
M Kerkmann et al.
JOURNAL OF IMMUNOLOGY (2003)
Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation
KJ Ishii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Phosphodiester CpG oligonucleotides as adjuvants:: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo
AH Dalpke et al.
IMMUNOLOGY (2002)
NK cells and NKT cells in innate defense against viral infections
CA Biron et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
The role of CpG motifs in innate immunity
AM Krieg
CURRENT OPINION IN IMMUNOLOGY (2000)
Share Paper
